Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History.
Eapen M, Malec LM, Armant MA, Johnson BD, Shi Q, Xu H, Du LM, Jerkins JH, Duffy LJ, Bushman FD, Lee C, Petrichenko A, Hematti P, Brazauskas R, Jobe SM, Hari PN, Wilcox DA. Eapen M, et al. Among authors: jerkins jh. N Engl J Med. 2025 Jan 23;392(4):412-414. doi: 10.1056/NEJMc2415164. N Engl J Med. 2025. PMID: 39842018 Free PMC article. No abstract available.
Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease.
Shah R, Murphy D, Logue M, Jerkins J, Jallouk A, Adetola K, Oluwole O, Jayani R, Biltibo E, Kim TK, Sengsayadeth S, Chinratanalab W, Kitko C, Savani B, Dholaria B. Shah R, et al. Among authors: jerkins j. Clin Hematol Int. 2024 Oct 21;6(4):74-88. doi: 10.46989/001c.124926. eCollection 2024. Clin Hematol Int. 2024. PMID: 39469117 Free PMC article. Review.
Progressive multifocal leukoencephalopathy after CAR-T cell therapy.
Montoya M, Harmsen HJ, Baer B, Long N, Messimore A, Jayani RV, Kassim A, Jallouk AP, Jerkins J, Biltibo EA, Savani BN, Dholaria B, Oluwole O, Morgan DS. Montoya M, et al. Among authors: jerkins j. Bone Marrow Transplant. 2024 Dec;59(12):1780-1782. doi: 10.1038/s41409-024-02410-3. Epub 2024 Sep 10. Bone Marrow Transplant. 2024. PMID: 39256585 No abstract available.
Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
Winget MD, Gatwood K, Jayani R, Biltibo E, Jallouk A, Jerkins J, Dholaria B, Kim TK, Savani B, Kassim A, McNeer E, Choi L, Orton L. Winget MD, et al. Among authors: jerkins j. Transplant Cell Ther. 2024 Oct;30(10):1031.e1-1031.e9. doi: 10.1016/j.jtct.2024.07.020. Epub 2024 Jul 27. Transplant Cell Ther. 2024. PMID: 39074685 Free article.
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation.
Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, Longo W, Hamadani M. Chhabra S, et al. Among authors: jerkins jh. Bone Marrow Transplant. 2024 Mar;59(3):373-379. doi: 10.1038/s41409-023-02178-y. Epub 2024 Jan 4. Bone Marrow Transplant. 2024. PMID: 38177221
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM. Chhabra S, et al. Among authors: jerkins jh. Transplant Cell Ther. 2023 Mar;29(3):174.e1-174.e10. doi: 10.1016/j.jtct.2022.11.029. Epub 2022 Dec 6. Transplant Cell Ther. 2023. PMID: 36494017 Free article.
Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885].
Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Chhabra S, et al. Among authors: jerkins jh. Transplant Cell Ther. 2022 Oct;28(10):717. doi: 10.1016/j.jtct.2021.01.005. Epub 2021 Jan 10. Transplant Cell Ther. 2022. PMID: 36202527 Free article. No abstract available.
Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination.
Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR. Chhabra S, et al. Among authors: jerkins jh. Haematologica. 2023 Jan 1;108(1):250-256. doi: 10.3324/haematol.2022.281309. Haematologica. 2023. PMID: 36106394 Free PMC article. No abstract available.
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.
Monahan K, Kleman A, Thapa B, Szabo A, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Hamadani M, Hari PN, Chhabra S. Monahan K, et al. Among authors: jerkins jh. Biol Blood Marrow Transplant. 2020 Dec;26(12):2229-2236. doi: 10.1016/j.bbmt.2020.08.030. Epub 2020 Sep 11. Biol Blood Marrow Transplant. 2020. PMID: 32920204 Free article. Clinical Trial.
31 results